• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Life Sciences | News, Analysis, Insights - HIT Consultant

ALZpath Secures Funding for Blood-Based Biomarker Testing for Alzheimer’s Disease Detection

by Fred Pennic 07/21/2023 Leave a Comment

ALZpath Secures Funding for Blood-Based Biomarker Testing for Alzheimer's Disease Detection

What You Should Know:  - ALZpath, a developer of blood-based diagnostic biomarker testing for Alzheimer's disease detection receives funding from the Alzheimer’s Drug Discovery Foundation (ADDF)’s Diagnostics Accelerator to accelerate the clinical availability  of ALZpathDx as a laboratory developed test (LDT).  - ALZpathDx is a novel, proprietary assay for blood-based measurement of phosphorylated tau at threonine 217 (pTau217), a highly accurate, diagnostic biomarker for
Read More

SiPhox Health Secures $27M for Lab-Grade Home Health Testing with Silicon Photonics

by Fred Pennic 07/19/2023 Leave a Comment

SiPhox Health Secures $27M for Lab-Grade Home Health Testing with Silicon Photonics

What You Should Know:  - Today, SiPhox Health, a Burlington, MA-based company building the next generation of lab-grade home health testing with silicon photonics raises $27M in funding, including a $10M Seed led by Khosla Ventures and Y Combinator, and a $17M Series A led by Intel Capital. - The SiPhox Home and Health testing systems offer innovative and efficient blood collection solutions for consumers, healthcare systems, pharmaceutical companies, and research teams focusing on
Read More

The Problem With Modern Disinfectants & What The Future of Infection Protection Should Look Like

by Dr. Vikram K. Kanmukhla, VP of Technical Product Management for AvantGuard, Inc. 07/19/2023 Leave a Comment

The Problem With Modern Disinfectants & What The Future of Infection Protection Should Look Like

Keeping surfaces pathogen-free is crucial in preventing the transmission of diseases and infections. Pathogens are microorganisms that can cause illness, and they can easily spread from contaminated surfaces to people who come into contact with those surfaces. This is a major concern in healthcare settings such as hospitals, where pathogens can spread easily and cause infections in vulnerable patients. In addition, pathogen spread can also occur in public places such as schools, workplaces, and
Read More

Eli Lilly Acquires Obesity Drug Maker Versanis for $1.9B

by Fred Pennic 07/14/2023 Leave a Comment

Eli Lilly Acquires Obesity Drug Maker Versanis for $1.9B

What You Should Know:  Eli Lilly announced an agreement to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases for $1.925B in cash. Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling. Bimagrumab is currently being assessed in the BELIEVE Phase 2b study alone and in combination with
Read More

Causaly Secures $60M to Accelerate AI-Powered Biomedical Research

by Fred Pennic 07/13/2023 Leave a Comment

Causaly Secures $60M to Accelerate AI-Powered Biomedical Research

What You Should Know:  Causaly, the leading AI platform for biomedical research raises $60M in Series B funding led by ICONIQ Growth, with participation from Index Ventures, Marathon Venture Capital, EBRD, Pentech Ventures and Visionaries Club. Strategic individuals also participated in the round, including Alex Gorsky (former Chairman and CEO of Johnson & Johnson) and Olivier Pomel (CEO and Co-Founder of Datadog). The investment brings the total funding raised to $93 million,
Read More

Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices

by Fred Pennic 07/12/2023 Leave a Comment

Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices

What You Should Know:  The Israel Innovation Authority announced today a NIS 113M ($31M USD) investment for the establishment of a center that will provide research and development (R&D) infrastructure for bio-devices based on bio-chips. The investment is part of the National Bio-Convergence Program.Bio-convergence represents the integration of biology and life sciences with engineering and software technologies. The investment is directed at companies dedicated to developing key
Read More

Why PV Signal Teams Must Leverage RWD & Advanced Cognitive Computing

by Art Brown, Director of Product Marketing, LifeSphere Clinical, ArisGlobal 07/12/2023 Leave a Comment

Why PV Signal Teams Must Leverage RWD & Advanced Cognitive Computing

Signal detection — one of the most critical activities within pharmacovigilance (PV) — is the process of searching for and identifying safety signals from a variety of data sources. PV teams typically monitor safety signals for post-market products by reviewing scientific and medical literature, data obtained from clinical studies, and individual case safety reports (ICSRs).  ICSRs gather data supporting reporting adverse events (AEs), product problems, and customer complaints associated
Read More

Verily & L’Oreal Launches Diverse Skin and Hair Health Registry

by Fred Pennic 07/10/2023 Leave a Comment

Verily & L’Oreal Launches Diverse Skin and Hair Health Registry

What You Should Know:  Today, Verily and L’Oreal announced the launch of a multi-year study, My Skin & Hair Journey, to advance precision skin and hair health. This is part of the two companies' multi-year partnership and research collaboration. The My Skin & Hair Journey registry will enroll thousands of self-identifying U.S. women to develop an unprecedented body of knowledge about perceptions and experiences of skin and hair health, including the role of lifestyle,
Read More

Volume and Cost of Clinical Lab Tests Expected to Rise in 2023

by Fred Pennic 07/05/2023 Leave a Comment

Volume and Cost of Clinical Lab Tests Expected to Rise in 2023

What You Should Know:  According to a new report on lab trends, the overall number of routine lab tests declined from 2021 to 2022, largely due to a reduction in COVID-19 tests. However, the number of non-COVID tests rose during the same period and is expected to continue to grow, along with overall spending on tests.The 2023 Lab Trend Report comes from Avalon Healthcare Solutions, a Lab Insights company that provides an annual evaluation of the status of U.S. clinical lab testing and an
Read More

Abbott Receives FDA Approval for World’s First Dual Chamber Leadless Pacemaker

by Jasmine Pennic 07/05/2023 Leave a Comment

Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker

What You Should Know:  The U.S. Food and Drug Administration (FDA) approves Abbott’s AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms.Abbott’s breakthrough technology enables the world's first beat-to-beat, wireless communication and synchronization between two leadless pacemakers, which are smaller than a AAA batteryLeadless pacemakers provide a new minimally invasive option
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 42
  • Go to page 43
  • Go to page 44
  • Go to page 45
  • Go to page 46
  • Interim pages omitted …
  • Go to page 92
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |